Pruritus in the elderly

Clinics in Dermatology

Volumn 29, Issue 1, 2011, Pages 15-23

  Reich, Adam ^a   Ständer, Sonja ^b   Szepietowski, Jacek C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANANDAMIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; APREPITANT; BENZOCAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CAPSAICIN; CARBAMAZEPINE; CEPHALOSPORIN; CHLORAMBUCIL; COLESTYRAMINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXEPIN; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MENTHOL; METHYLDOPA; NALFURAFINE; ONDANSETRON; PALMIDROL; PENICILLIN G; PIMECROLIMUS; POLIDOCANOL; TACROLIMUS; TICLOPIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACUPUNCTURE; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE SKIN DISEASE; BLISTER; COMORBIDITY; CONNECTIVE TISSUE DISEASE; CONTACT DERMATITIS; CUTANEOUS PARAMETERS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE INCREASE; ELDERLY CARE; ELECTROACUPUNCTURE; ERYTHEMA; HUMAN; INDIVIDUALIZATION; MASTOCYTOSIS; MEDICAL ASSESSMENT; PATIENT CARE; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PSYCHOTHERAPY; ROSACEA; SCRATCHING; SKIN DISEASE; SKIN INFECTION; SKIN INFLAMMATION; SKIN LYMPHOMA; SYMPTOM; UNPLEASANT SENSATION; XEROSIS;

AGED; AGED, 80 AND OVER; HUMANS; PRURITUS; SKIN AGING;

EID: 78650010382     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.07.002     Document Type: Article

References (61)

1. Ständer S., Weisshaar E., Mettang T., et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007, 87:291-294.
2. Twycross R., Greaves M.W., Handwerker H., et al. Itch: scratching more than the surface. QJM 2003, 96:7-26.
3. Bernhard J.D. Itch and pruritus: what are they, and how should itches be classified?. Dermatol Ther 2005, 18:288-291.
4. Misery L., Alexandre S., Dutray S., et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French psychodermatology group. Acta Derm Venereol 2007, 87:341-344.
5. Misery L., Wallengren D.J., Weisshaar E., Zalewska A. Validation of diagnosis criteria of functional itch disorder or psychogenic pruritus. Acta Derm Venereol 2008, 88:503-504.
6. Reich A., Ständer S., Szepietowski J.C. Drug-induced pruritus: a review. Acta Derm Venereol 2009, 89:236-244.
7. Ständer S., Streit M., Darsow U., et al. Diagnostisches und therapeutisches Vorgehen bei chronischem Pruritus. J Dtsch Dermatol Ges 2006, 4:350-370.
8. Shirin H., Schapiro J.M., Arber N Pinkhas J., Sidi Y., Salomon F. Erythromycin base-induced rash and liver function disturbances. Ann Pharmacother 1992, 26:1522-1523.
9. Reich A., Szepietowski J.C. Opioid-induced pruritus: an update. Clin Exp Dermatol 2010, 35:2-6.
10. Odeh M., Oliven A. Verapamil-associated liver injury. Harefuah 1998, 134:36-37.
11. Kowdley K.V., Keeffe E.B., Fawaz K.A. Prolonged cholestasis due to trimethoprim sulfamethoxazole. Gastroenterology 1992, 102:2148-2150.
12. Larrey D., Amouyal G., Pessayre D., et al. Amitriptyline-induced prolonged cholestasis. Gastroenterology 1988, 94:200-203.
13. Metze D., Reimann S., Szépfalusi Z., Bohle B., Kraft D., Luger T.A. Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol 1997, 136:553-559.
14. Bernhard J.D. Phantom itch, pseudophantom itch, and senile pruritus. Int J Dermatol 1992, 31:856-857.
15. Ward J.R., Bernhard J.D. Willan's itch and other causes of pruritus in the elderly. Int J Dermatol 2005, 44:267-273.
16. Weisshaar E., Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009, 89:339-350.
17. Yalçin B., Tamer E., Toy G.G., Ozta P., Hayran M., Alli N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 2006, 45:672-676.
18. Norman R.A. Xerosis and pruritus in the elderly: recognition and management. Dermatol Ther 2003, 16:254-259.
19. Beauregard S., Gilchrest B.A. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987, 123:1638-1643.
20. Grundmann S.A., Ständer S. Evaluation of chronic pruritus in older patients. Aging Health 2010, 6:53-66.
21. Fisher G.J., Wang Z.Q., Datta S.C., Varani J., Kang S., Voorhees J.J. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997, 337:1419-1428.
22. Landau M. Exogenous factors in skin aging. Curr Probl Dermatol 2007, 35:1-13.
23. Uitto J. The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure. J Drugs Dermatol 2008, 7(2 suppl):s12-6.
24. Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev 2002, 123:801-810.
25. Farage M.A., Miller K.W., Elsner P., Maibach H.I. Functional and physiological characteristics of the aging skin. Aging Clin Exp Res 2008, 20:195-200.
26. Waller J.M., Maibach H.I. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol 2005, 11:221-235.
27. Waller J.M., Maibach H.I. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol 2006, 12:145-154.
28. Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol 1998, 25:153-157.
29. Akimoto K., Yoshikawa N., Higaki Y., Kawashima M., Imokawa G. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol 1993, 20:1-6.
30. Szepietowski J.C., Reich A. Evaluation of pruritus. Epocrates Online Available at:, Last updated: Feb 6, 2009. https://online.epocrates.com/u/2911612/Evaluation+of+pruritus.
31. Reich A., Heisig M., Szepietowski J.C. Visual Analogue Scale as a validated assessment of pruritus intensity. Acta Derm Venereol 2009, 89:688.
32. Phan N.Q., Ständer S. Assessment of pruritus intensity: correlation between visual analogue scale, numeric rating scale and verbal rating scale in patients with chronic pruritus. Acta Derm Venereol 2009, 89:713.
33. Szepietowski J., Reich A. Pruritus: pathomechanism, clinics, treatment 2010, Termedia Publishing House, Poznan.
34. Wsik F., Szepietowski J., Szepietowski T., Weyde W. Relief of uraemic pruritus after balneological therapy with a bath oil containing polidocanol (Balneum Hermal Plus). An open clinical study. J Dermatol Treat 1996, 7:231-233.
35. Freitag G., Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Current Med Res Opin 1997, 13:529-537.
36. Drake L.A., Fallon J.D., Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994, 31:613-616.
37. Drake L.A., Millikan L.E. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995, 131:1403-1408.
38. Smith P.F., Corelli R.L. Doxepin in the management of pruritus associated with allergic cutaneous reactions. Ann Pharmacother 1997, 31:633-635.
39. Wallengren J., Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995, 32:287-289.
40. Ständer S., Luger T., Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001, 44:471-478.
41. Pauli-Magnus C., Klumpp S., Alscher D.M., Kuhlmann U., Mettang T. Short-term efficacy of tacrolimus oinment in severe uremic pruritus. Perit Dial Int 2000, 20:802-803.
42. Duque M.I., Yosipovitch G., Fleischer A.B., Willard J., Freedman B.I. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 2005, 52:519-521.
43. Szepietowski J.C., Reich A., Szepietowski T. Emollients with endocannabinoids in the treatment of uraemic pruritus: discussion of the therapeutic options. Ther Apher Dial 2005, 9:277-279.
44. Stander S., Reinhardt H.W., Luger T.A. Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus. Hautarzt 2006, 57:801-807.
45. Eberlein B., Eicke C., Reinhardt H.W., Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008, 22:73-82.
46. Kupczyk P., Reich A., Szepietowski J.C. Cannabinoid system in the skin-a possible target for future therapies in dermatology. Exp Dermatol 2009, 18:669-679.
47. Kobza Black A. H1 antagonists in the management of the itch in urticarias. Skin Pharmacol 1992, 5:21-24.
48. Metze D., Reimann S., Beissert S., Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999, 41:533-539.
49. Bergasa N.V., Talbot T.L., Alling D.W., et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992, 102:544-549.
50. Kumagai H., Ebata T., Takamori K., Muramatsu T., Nakamoto H., Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010, 25:1251-1257.
51. Schworer H., Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Invest 1993, 71:659-662.
52. Loosemore M.P., Bordeaux J.S., Bernhard J.D. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy. J Eur Acad Dermatol Venereol 2007, 21:1440-1441.
53. Sheen M.J., Ho S.T., Lee C.H., Tsung Y.C., Chang F.L. Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. Anesth Analg 2008, 106:1868-1872.
54. Razeghi E., Eskandari D., Ganji M.R., Meysamie A.P., Togha M., Khashayar P. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail 2009, 31:85-90.
55. Goutos I., Eldardiri M., Khan A.A., Dziewulski P., Richardson P.M. Comparative evaluation of antipruritic protocols in acute burns. The emerging value of gabapentin in the treatment of burns pruritus. J Burn Care Res 2010, 31:57-63.
56. Shaw R.J., Dayal S., Good J., Bruckner A.L., Joshi S.V. Psychiatric medications for the treatment of pruritus. Psychosom Med 2007, 69:970-978.
57. Ständer S., Böckenholt B., Schürmeyer-Horst F., et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol 2009, 89:45-51.
58. Ständer S., Siepmann D., Luger T.A. Targeting the neurokinin receptor 1 as a new antipruritic strategy: results of a case series with aprepitant. Acta Derm Venereol 2009, 89:717.
59. Szepietowski J.C., Morita A., Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses 2002, 58:167-170.
60. Gao H., Zhang W., Wang Y. Acupuncture treatment for 34 cases of uremic cutaneous pruritus. J Tradit Chin Med 2002, 22:29-30.
61. Lonsdale-Eccles A., Carmichael A.J. Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies. Drugs Aging 2003, 20:197-208.